Study to Assess Effect & Safety of High Dose of Biotin (Qizenday®) in

See also
Status	Clinical Trial	Phase
Completed	`NCT02282826` - A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis	Phase 1
Completed	`NCT02804594` - A Study of Oxidative Pathways in MS Fatigue	Phase 2
Completed	`NCT04120675` - Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis	N/A
Completed	`NCT01719159` - Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis	Phase 2
Enrolling by invitation	`NCT03552211` - Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis
Recruiting	`NCT05740722` - Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis	Phase 2
Completed	`NCT03980145` - G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis	N/A
Completed	`NCT03269071` - Neural Stem Cell Transplantation in Multiple Sclerosis Patients	Phase 1
Not yet recruiting	`NCT05811013` - Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis	N/A
Not yet recruiting	`NCT04289909` - Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)	N/A
Recruiting	`NCT05685784` - Multiple Sclerosis Prediction and Monitoring of Progression Study	N/A
Completed	`NCT03493841` - Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis	Phase 1
Recruiting	`NCT05441488` - Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis	Phase 3
Recruiting	`NCT04695080` - ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis	Phase 2/Phase 3
Recruiting	`NCT06451159` - A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis	Phase 1
Completed	`NCT03423121` - A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis	Phase 1/Phase 2
Terminated	`NCT02580669` - Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis	N/A
Enrolling by invitation	`NCT05706220` - Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
Recruiting	`NCT01815632` - Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)	Phase 2
Recruiting	`NCT01364246` - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica	Phase 1/Phase 2

NCT number	NCT03302806
Study type	Observational
Source	Nantes University Hospital
Contact
Status	Completed
Phase
Start date	June 29, 2016
Completion date	October 24, 2018

Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis — BIOSEP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms